Product
PENTAXIM
1 clinical trial
3 indications
Indication
DiphtheriaIndication
TetanusIndication
PertussisClinical trial
To Evaluate Safety and Preliminary Immunogenicity of the Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine in Children Aged 2 Months to 6 Years: A Randomized, Blinded, Active-controlled Phase I Clinical TrialStatus: Recruiting, Estimated PCD: 2024-12-15